startup.bid
ZH
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

WonderTx

Extrapolative AI to unlock First-in-Class drugs

公司介绍

公司介绍(英文)

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery.  This should dramatically increase our probability of success.

There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

主题

所在地
旧金山, CA, 美国
团队规模
3 名员工
YC 批次
Summer 2026
状态
运营中
阶段
早期阶段

同类创业公司与竞争对手

问答

WonderTx 的总部在哪里?

旧金山, CA, 美国

WonderTx 有多少名员工?

根据公司资料,共有 3 名员工。

WonderTx 获得过融资吗?

我们的数据中没有 WonderTx 的融资记录。

WonderTx 有哪些同类公司和竞争对手?

同类创业公司:Diffuse Bio、Output Labs和Numerion Labs。